Literature DB >> 21484824

Single-fiber conduction velocity test allows earlier detection of abnormalities in diabetes.

Luca Padua1, Erik Stålberg, Pietro Caliandro, Giovanna Muscogiuri, Costanza Pazzaglia, Gian Pio Sorice, Giuseppe Granata, Enrica Salomone, Alfredo Pontecorvi, Andrea Giaccari.   

Abstract

INTRODUCTION: The purpose of this study was to determine whether single-fiber conduction velocity (SF-CV) of a small number of axons increases sensitivity for identification of motor nerve conduction alterations in patients with diabetes.
METHODS: Twenty-one consecutive diabetic patients in good metabolic control were studied. For each patient, conventional (C-CV) and SF-CV results were correlated with the presence of neuropathic symptoms.
RESULTS: Nine of 21 patients reported symptoms suggestive of mild nerve impairment. Three patients had abnormal sural nerve CV, 1 of whom also had abnormal motor nerve conduction. Eighteen patients had normal findings on conventional tests, 3 of whom had slowing of SF-CV.
CONCLUSIONS: SF-CV is able to detect mild myelin damage with higher sensitivity than conventional tests. The use of SF-CV may be a helpful tool in the early identification of diabetic polyneuropathy, and it may be useful for tailoring an approach to diabetic polyneuropathy.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21484824     DOI: 10.1002/mus.21935

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  2 in total

1.  Sustained atypical myokymia of the abductor pollicis brevis with a focal slowing of the median nerve motor axons at the wrist.

Authors:  Nagako Murase; Masahiro Goto; Nobuo Kohara; Jun Kimura
Journal:  Clin Neurophysiol Pract       Date:  2020-12-17

2.  Elevated protein carbonylation, and misfolding in sciatic nerve from db/db and Sod1(-/-) mice: plausible link between oxidative stress and demyelination.

Authors:  Ryan T Hamilton; Arunabh Bhattacharya; Michael E Walsh; Yun Shi; Rochelle Wei; Yiqiang Zhang; Karl A Rodriguez; Rochelle Buffenstein; Asish R Chaudhuri; Holly Van Remmen
Journal:  PLoS One       Date:  2013-06-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.